Thompson Investment Management, Inc. Neurocrine Biosciences Inc Transaction History
Thompson Investment Management, Inc.
- $652 Million
- Q1 2025
A detailed history of Thompson Investment Management, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 9,755 shares of NBIX stock, worth $988,961. This represents 0.17% of its overall portfolio holdings.
Number of Shares
9,755
Previous 8,830
10.48%
Holding current value
$988,961
Previous $1.21 Million
10.54%
% of portfolio
0.17%
Previous 0.18%
Shares
16 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
95.9MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.44 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.03 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$496 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$306 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$257 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $9.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...